Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy
Articolo
Data di Pubblicazione:
2023
Citazione:
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy / Rossi, G., Petrone, M.C., Schiavo Lena, M., Albarello, L., Palumbo, D., Testoni, S.G.G., Archibugi, L., Tacelli, M., Zaccari, P., Vanella, G., Apadula, L., Crippa, S., Belfiori, G., Reni, M., Falconi, M., Doglioni, C., De Cobelli, F., Healey, A.J., Capurso, G., Arcidiacono, P.G.. - In: DEN OPEN. - ISSN 2692-4609. - 3:1(2023). [10.1002/deo2.152]
Abstract:
Endoscopic ultrasound (US)-guided radiofrequency ablation (RFA) has been investigated for pancreatic ductal adenocarcinoma (PDAC) but studies are limited and heterogeneous. Computed tomography (CT) scan features may predict RFA response after chemotherapy but their role is unexplored. The primary aim was to investigate the efficacy of ex-vivo application of a dedicated RFA system at three power on surgically resected PDAC in patients who underwent neoadjuvant chemotherapy. The secondary aim was to explore the association between pre-treatment CT-based quantitative features and RFA response.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Rossi, Gemma; Petrone, Maria Chiara; Schiavo Lena, Marco; Albarello, Luca; Palumbo, Diego; Testoni, Sabrina Gloria Giulia; Archibugi, Livia; Tacelli, Matteo; Zaccari, Piera; Vanella, Giuseppe; Apadula, Laura; Crippa, Stefano; Belfiori, Giulio; Reni, Michele; Falconi, Massimo; Doglioni, Claudio; De Cobelli, Francesco; Healey, Andrew J; Capurso, Gabriele; Arcidiacono, Paolo Giorgio
Link alla scheda completa:
Link al Full Text:
Pubblicato in: